Neuroimaging Study of Exercise and Memory Function (EMF)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02057354 |
Recruitment Status :
Completed
First Posted : February 7, 2014
Last Update Posted : April 25, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Aging | Behavioral: Aerobic Exercise Behavioral: Non-Aerobic Exercise | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 190 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Aerobic Exercise, Neurotrophins, and fMRI of Hippocampal Function and Structure |
Actual Study Start Date : | April 2014 |
Actual Primary Completion Date : | January 2018 |
Actual Study Completion Date : | March 2018 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Healthy Sedentary Young Adults
Participants 18-35 years of age will be randomized to either aerobic or non-aerobic exercise training.
|
Behavioral: Aerobic Exercise
The goal of the aerobic exercise training is to increase aerobic endurance. Walking on treadmill at moderate intensity with grade adjusted. Exercise tailored to individual ability level.
Other Name: Endurance Training Behavioral: Non-Aerobic Exercise The goal of this training is to improve overall muscle strength, balance and flexibility. Participants will do strength, balance and stretching exercises. Exercises tailored to individual ability level.
Other Name: Strength, balance, stretching |
Experimental: Healthy Sedentary Older Adults
Participants 55-85 years of age will be randomized to either aerobic or non-aerobic exercise training.
|
Behavioral: Aerobic Exercise
The goal of the aerobic exercise training is to increase aerobic endurance. Walking on treadmill at moderate intensity with grade adjusted. Exercise tailored to individual ability level.
Other Name: Endurance Training Behavioral: Non-Aerobic Exercise The goal of this training is to improve overall muscle strength, balance and flexibility. Participants will do strength, balance and stretching exercises. Exercises tailored to individual ability level.
Other Name: Strength, balance, stretching |
- MRI [ Time Frame: 1.5 to 2 hours each at Visits 4 and 43 ]Measurement of brain activity during task performance and measurement of change in regional brain volumes.
- Serum BDNF level [ Time Frame: 5 minutes each at Visits 4 and 43 ]Fasting blood draw on same day of MRI to measure change in serum BDNF from baseline to follow-up
- Memory test performance [ Time Frame: 1.5 to 2 hours each at Visits 4 and 43 ]Participants will perform recognition memory tests during and after functional MRI. Measurements include baseline-to-follow-up change in reaction times and accuracy.
- Aerobic capacity and muscle strength [ Time Frame: 80 min each at Visits 2, 3, 41 and 42 ]Participants will perform two treadmill tests and several muscle strength tests to estimate baseline-to-follow-up change in aerobic capacity, measure change in time on treadmill, and determine change in muscle strength.
- Blood cortisol levels [ Time Frame: 5 min each at Visits 4 and 43 ]Cortisol levels will be obtained from the blood sample drawn during baseline and follow-up.
- Anthropometric measurements [ Time Frame: 10 minutes each during Visits 2 and 41 ]Anthropometric measurements include height, weight, and body mass index. Percent body fat will also be estimated.
- Blood serum levels of other neurotrophins [ Time Frame: 5 min each at Visit 4 and 43 ]The blood draw will be used for other neurotrophins related to exercise and cognition.
- Neuropsychological test performance [ Time Frame: 15-30 minutes each at Visits 4 and 43 ]Baseline-to-follow-up change in performance of the Wechsler Adult Intelligence Scale-IV subtests

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Non-smoking
- Age between 18-35 years or between 55-85 years
- Sedentary status (physically inactive)
- Generally healthy
- Native-English speaker
Exclusion Criteria:
- Diagnosis of severe anemia
-
Past or present condition that affect cognitive functioning:
- learning disability
- neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)
- psychiatric disorders or conditions (depression, anxiety disorder, etc.)
- Poor vision that cannot be corrected with glasses or contact lenses
- Presence of an infection
- Diagnosis of kidney failure
- Diagnosis of liver disease
- Diagnosis of thyrotoxicosis/hyperthyroidism
- Diagnosis of cancer
-
Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and physical exercise:
- heart (e.g. heart attack, arrhythmias, etc.)
- circulatory (e.g. uncontrolled hypertension, high cholesterol, etc.)
- respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)
- current musculoskeletal impairments (e.g. leg claudication, fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)
- diagnosis of electrolyte disorder or abnormality
- presence of diabetes mellitus
- Claustrophobia (fear of small, encloses spaces)
- Female subjects: breast-feeding or potentially pregnant
- Obesity
- Eating disorder
- Compulsive exercising
- Ferro-magnetic metal in or on the body that cannot be removed (e.g. pacemaker, defibrillator, permanent tattoo or eyeliner with metallic specks)
- Prescription medication or other drugs that are cardio-active
- Prescription medication or other drugs that are psycho-active
- Drug abuse or alcohol misuse
- Regularly exercising
- Unavailable for the approximately 4-month duration of the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02057354
United States, Massachusetts | |
Boston University School of Medicine | |
Boston, Massachusetts, United States, 02118 |
Principal Investigator: | Karin Schon, PhD | Boston University |
Responsible Party: | Karin Schon, Assisstant Professor, Department of Anatomy & Neurobiology, BUSM, Boston University |
ClinicalTrials.gov Identifier: | NCT02057354 |
Other Study ID Numbers: |
H-32635 R00AG036845 ( U.S. NIH Grant/Contract ) |
First Posted: | February 7, 2014 Key Record Dates |
Last Update Posted: | April 25, 2018 |
Last Verified: | April 2018 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Brain Brain-Derived Neurotrophic Factor Brain Mapping Cognition Exercise Hippocampus Hydrocortisone Learning |
Memory Magnetic Resonance Imaging Nerve Growth Factors Neuroimaging Physical Endurance Physical Fitness Resistance Training Walking |